P. Rizza

发表

FoxO3a Mediates the Inhibitory Effects of the Antiepileptic Drug Lamotrigine on Breast Cancer Growth

S. Andò, M. Pellegrino, P. Rizza, 2018, Molecular Cancer Research.

Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation

C. Giordano, I. Barone, S. Catalano, 2009, Journal of cellular physiology.

Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination

C. Giordano, S. Catalano, S. Andò, 2012, Breast Cancer Research and Treatment.

Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines

I. Barone, S. Catalano, S. Andò, 2014, Breast Cancer Research.

Ligand activated progesterone receptor B drives autophagy-senescence transition through a Beclin-1/Bcl-2 dependent mechanism in human breast cancer cells

S. Andò, D. Bonofiglio, M. Pellegrino, 2016, Oncotarget.

T3 enhances thyroid cancer cell proliferation through TRβ1/Oct-1-mediated cyclin D1 activation

S. Catalano, S. Andò, D. Bonofiglio, 2014, Molecular and Cellular Endocrinology.

Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells.

C. Giordano, I. Barone, S. Catalano, 2012, Endocrinology.

Rapid Estradiol/ER (cid:1) Signaling Enhances Aromatase Enzymatic Activity in Breast Cancer Cells

C. Giordano, I. Barone, S. Catalano, 2009 .

Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells.

C. Giordano, S. Catalano, S. Andò, 2004, The Journal of biological chemistry.

Evidences that estrogen receptor α interferes with adiponectin effects on breast cancer cell growth

S. Catalano, S. Andò, D. Bonofiglio, 2014, Cell cycle.

Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter

S. Fuqua, C. Giordano, I. Barone, 2012, Breast Cancer Research and Treatment.

Fas ligand expression in TM4 sertoli cells is enhanced by estradiol “in situ” production

C. Giordano, I. Barone, S. Catalano, 2007, Journal of cellular physiology.

Production of Plant-Derived Oleuropein Aglycone by a Combined Membrane Process and Evaluation of Its Breast Anticancer Properties

L. Giorno, M. Pellegrino, P. Rizza, 2020, Frontiers in Bioengineering and Biotechnology.

Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation.

S. Andò, P. Rizza, I. Casaburi, 2010, Molecular nutrition & food research.

3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression.

S. Catalano, S. Andò, Aurélien Lesnard, 2016, European journal of medicinal chemistry.

DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation

C. Giordano, I. Barone, S. Catalano, 2013, Cell Death and Disease.

Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis.

C. Giordano, P. Plastina, I. Barone, 2015, Biochimica et biophysica acta.

FoxO3a Inhibits Tamoxifen-Resistant Breast Cancer Progression by Inducing Integrin α5 Expression

C. Giordano, I. Barone, D. Bonofiglio, 2022, Cancers.

FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer

C. Giordano, D. Bonofiglio, F. Sotgia, 2019, Cancers.

Leptin Enhances, via AP-1, Expression of Aromatase in the MCF-7 Cell Line*

C. Giordano, S. Catalano, S. Andò, 2003, Journal of Biological Chemistry.

17β-Estradiol enhances α5 integrin subunit gene expression through ERα–Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells

S. Catalano, S. Andò, P. Rizza, 2010, Breast Cancer Research and Treatment.

Leptin Induces, via ERK1/ERK2 Signal, Functional Activation of Estrogen Receptor α in MCF-7 Cells*

C. Giordano, S. Catalano, S. Andò, 2004, Journal of Biological Chemistry.

Rapid estradiol/ERalpha signaling enhances aromatase enzymatic activity in breast cancer cells.

C. Giordano, I. Barone, S. Catalano, 2009, Molecular endocrinology.

Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity

B. Győrffy, C. Giordano, I. Barone, 2015, Oncotarget.

Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor

S. Andò, M. Pellegrino, P. Rizza, 2016, Oncotarget.

Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines

I. Barone, S. Catalano, S. Andò, 2014, Breast Cancer Research.

Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth

S. Fuqua, C. Giordano, I. Barone, 2014, Breast Cancer Research and Treatment.

GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo

L. Cerquetti, D. Amendola, A. Stigliano, 2015, Oncotarget.

In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer.

S. Catalano, S. Andò, D. Bonofiglio, 2011, The American journal of pathology.

Conditional expression of Ki-RasG12V in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ERα)-positive adenocarcinoma

I. Barone, S. Catalano, S. Andò, 2017, Oncogene.

Evidence that the mouse insulin receptor substrate-1 belongs to the gene family on which the promoter is activated by estrogen receptor alpha through its interaction with Sp1.

S. Andò, P. Rizza, C. Morelli, 2006, Journal of molecular endocrinology.

Estrogen receptor‐α drives adiponectin effects on cyclin D1 expression in breast cancer cells

S. Catalano, S. Andò, D. Bonofiglio, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

FoxO 3 a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer

C. Giordano, D. Bonofiglio, F. Sotgia, 2019 .

Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression

S. Fuqua, C. Giordano, L. Gelsomino, 2011, Oncogene.